Specialty biopharmaceutical company Cerimon Pharmaceuticals has named Ayse Kocak VP of Marketing. Kocak will be responsible for evaluating and developing commercial strategies around the company's evolving pain and autoimmune pipeline and managing the company's marketing efforts. Kocak most recently served as marketing director for Pfizer's Geodon US psychosis team. In this position, Kocak oversaw the development and implementation of business strategies for Geodon, a drug for the treatment of schizophrenia. During her tenure, sales of Geodon grew by over 30%, and Geodon is now the fastest-growing antipsychotic drug. Prior, Kocak served as marketing director, for Inspra’s US team at Pfizer, and led the US launch of Inspra for the treatment of patients who develop heart failure following a heart attack.
Specialty pharmaceutical firm Alpharma has hired Stefan Aigner as EVP, corporate and business development. Prior to joining Alpharma, Aigner was co-founder and EVP of business development at Reliant Pharmaceuticals.
King Pharmaceuticals said its board of directors has appointed Brian Markison to succeed Ted Wood as the chairman of the board. The appointment will be effective at the close of the company's May 2007 annual meeting of shareholders. Wood will remain a member of King's board and will serve as lead independent director. Markison will continue as King's president and CEO.
Allergan appointed Deborah Dunsire to the company's board of directors. Dunsire, president and chief executive officer of Cambridge, MA-based Millenium Pharmaceuticals will initially serve as a member of the corporate governance committee and the science and technology committee. Dunsire joined Millenium Pharmaceuticals in July 2005. She previously led the Novartis US oncology business, and is currently a board member at PhRMA. Dunsire was the 2000 recipient of the Health Care Business Women's Association Rising Star Award.
ImpactRx has named Richard Altus CEO. Altus, who joined ImpactRx in 2002, had been acting CEO since May. Before that he was chief financial officer for the company, which tracks pharmaceutical promotions. Before joining ImpactRx, Altus was COO for Medical Broadcasting Company.
Cadent Medical Communications, an inVentiv Health company, recently added Brooke Fugitt as biomedical editor to its staff. In this role, Fugitt will be responsible for copyediting, proofreading and verifying scientific accuracy of publications. Prior to Cadent Medical Communications, Fugitt served as a freelance editor for Holt, Rinehart and Winston, where she was responsible for copyediting and proofing client materials. Fugitt also wrote test-preparatory materials and educational features.
HealthEd has named Stephanie Murrin VP, creative director of copy and Linda Barber, copywriter. Carie Lyn Caldwell and Jeanne Sica have joined HealthEd’s project management team. Lee Wielgolinski has been named director of information technology.
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.